News | RIVM

Start cervical cancer screening on Saba

February 7th 2022, a pilot for population screening for cervical cancer will start on Saba. All women between 30 and 60 years, will be invited to participate in the coming three years.

Over half a million positive COVID-19 tests, more hospital admissions

Last week*, 530,015 positive COVID-19 tests were reported to RIVM**. That is an increase of 45% compared to the week before that. The number of new hospital admissions rose by 11% in the past week. ICU admissions rose by 18%.

Risks of chemical substances to human health and the environment

RIVM is developing methods to identify new and emerging risks of chemical substances to workers, consumers and the environment.

Use of other needles in Dutch Immunisation Programme as a precaution

As a result of the EenVandaag broadcast regarding the safety of injection needles, and after consultation with the Dutch Inspection for Health Care (IGZ), RIVM advises against the use of needles so

New insights on ammonia emissions

Calculated ammonia emissions in the Netherlands are still declining. However, emissions overall are greater than previously assumed.

Harmful substances in e-cigarettes assessed

While e-cigarettes are less harmful to health than tobacco cigarettes, the vapour from an e-cigarette contains substances and chemical impurities in concentrations that could be detrimental to heal

Reduced-sodium lunches result in decreased daily dietary sodium intakes

Consumption of reduced-sodium foods over a 3-week period was well accepted by uninformed participants in an experimental real-life canteen setting.

Utrecht Side Event International One Health Congress

Scientists and policy makers from around the world will visit research institutes and companies in the field of Life Sciences in the Utrecht region on March 18th.

Big Data gives more insight into the health impacts of air pollution

Long-term exposure to particulate air pollution and nitrogen dioxide has been found to be associated with total mortality and mortality from respiratory diseases and lung cancer in the Netherlands.